Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, in most cases you should declare Mounjaro on your travel insurance. Tirzepatide is a prescription-only medicine for a pre-existing health condition, and nearly all UK travel insurers require you to disclose any ongoing prescription treatment when you take out or renew a policy. Failing to declare it could leave a claim unpaid — even for something unrelated to your weight or medication. The good news is that declaring it is straightforward, and for most people it makes little difference to the premium.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most UK travel insurance policies define a pre-existing medical condition as any illness, injury or health condition for which you are currently taking prescribed medication. Mounjaro (tirzepatide) is a prescription-only medicine licensed for weight management, which means the definition catches it, regardless of how well-controlled your weight is or whether you feel perfectly healthy. The NHS guidance on tirzepatide confirms it is dispensed on prescription only, reinforcing insurers’ right to classify it this way.
The consequence of not declaring is worth understanding clearly. If you have an accident abroad and a claims handler discovers an undisclosed prescription in your medical records, the insurer may treat the whole policy as misrepresented, not just any Mounjaro-related element. That means a ski injury, a cancelled flight or a hospital admission for something entirely separate could go uncompensated. The risk is disproportionate to any small saving you might make by staying quiet.
There is also a softer reason to declare. Mounjaro carries a small risk of gastrointestinal symptoms (nausea, vomiting, diarrhoea) that can worsen with travel stress, unfamiliar food or heat. If you needed hospital care abroad for severe dehydration tied to those symptoms, undisclosed treatment would complicate any claim immediately. Declaring puts you on solid ground from the start.
When you get to the medical screening section of a travel insurance quote, you will be asked whether you are taking any prescribed medication or have any ongoing conditions. Answer yes, then name tirzepatide or Mounjaro. You may also be asked about the underlying condition being treated, typically obesity or a weight-related health condition such as high blood pressure or type 2 diabetes. Declare both the medicine and the condition.
Some insurers will ask a short series of follow-up questions: Is your condition stable? Have you been hospitalised in the past twelve months? Are you waiting for surgery? Most people on Mounjaro can answer those questions positively. The insurer then either covers the condition as standard, adds an exclusion for it, or applies a small loading to the premium. A loading is more common when there are multiple underlying conditions rather than for tirzepatide alone.
If you are considering how insurers handle the detail, our page on adding Mounjaro to your travel insurance walks through the screening process step by step. It is also worth reading your insurer’s policy wording before you travel rather than after, definitions of ‘pre-existing’ vary between providers, and some insurers like Admiral have published specific guidance on how they treat weight-loss medicines.
Declaration is only one part of the picture. Travelling with Mounjaro raises a few logistics that are worth sorting before your bags are packed, ideally not on a Monday morning when you’re already running late for a flight.
Mounjaro pens require refrigeration at 2–8 °C; once removed from the fridge they can be kept at room temperature only for the window stated in the Patient Information Leaflet, so check that carefully before you travel. On flights, pens should go in your carry-on luggage, hold temperatures are unpredictable and could damage the medicine. Carry a cool bag with an ice pack for transfers and excursions.
Many countries also require a letter from your prescriber confirming that you are carrying a prescription injectable medicine. A brief, signed letter on headed paper naming tirzepatide, the dose, and the fact that it is prescribed for you personally will satisfy most customs officials. If you are travelling outside the EU or to countries with stricter controlled-medicine rules, check the destination’s embassy requirements in advance, NHS England’s guidance on weight management injections notes that healthcare teams can support patients with documentation for travel. Our guide to using Mounjaro pens covers handling and storage in more detail.
Finally, think about disposal. A sharps container is a legal requirement in most countries for discarded needles. If you are travelling light, a small travel sharps container keeps you compliant without taking up much space in your bag.
If you are due a repeat before you travel, it is sensible to plan ahead. Private treatment through a service like ours involves a clinical review before each repeat order, there are no auto-renewals and no assumption that the previous month’s supply will simply arrive again. Factor in time for that review when planning around a holiday, and remember that the free consultation can be started at any point. For anyone thinking about cost alongside everything else, our page on Mounjaro pricing in the UK explains what a legitimate private prescription typically includes. Questions about eligibility or your specific health picture are best directed to a prescriber, our clinical team reviews every consultation personally, and the FAQs cover the most common pre-travel queries we hear. If you want to explore how Mounjaro affects travel insurance premiums more broadly, that page goes into insurer behaviour in depth.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.